We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cenix BioScience and Debiopharm Sign Research Agreement

News   May 23, 2013

 
Cenix BioScience and Debiopharm Sign Research Agreement
 
 
 

RELATED ARTICLES

New Imaging Tools that Trace Key Breast Cancer Enzymes May Help Guide Therapies

News

A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.

READ MORE

Universal Cancer Test: One Test to Diagnose Them All?

News

A diagnostic test is in the works to identify patterns of methyl groups, which are altered dramatically by cancer. The test uses gold nanoparticles that instantly change colour and indicate if the nanostructures of cancer DNA are present.

READ MORE

Fluidic Analytics Raises $31m to Launch Two New Products in Lab Tools Pipeline and Unlock Biology Behind Major Diseases

News

Proteins and their behaviour are crucial to understanding how diseases develop, identifying the way that drugs interact with their targets, and developing new methods for matching the right treatment to the right patient at the right time.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE